Immuron IMRN
NASDAQ IMRN
$0.95 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immuron (IMRN) Income towards Parent Company (2023 - 2024)

Updated

Immuron's Income towards Parent Company came in at -$3.82 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Income towards Parent Company (2023 - 2024) Analysis & Trends

Going back to FY2015, Immuron's Income towards Parent Company data covers 12 fiscal years.

  • The five-year range for annual Income towards Parent Company is -$5.22 million (FY2025) to -$28,543 (FY2022).
  • Per Business Quant, earlier fiscal years put Income towards Parent Company at -$5.22 million in FY2025, -$69,347 in FY2024, -$2.07 million in FY2023 and -$28,543 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Immuron 7.67 Mn -9.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.54 Mn
Sep 9, 2024 -46,223.37
Dec 31, 2023 -24,649.80
API Access

Immuron Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=IMRN&period=max&api_key=YOUR_API_KEY